Tamoxifen for the Treatment of Unfavorable Bleeding in Contraceptive Implant Users
Status:
Completed
Trial end date:
2015-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to study whether a drug called tamoxifen can reduce vaginal
bleeding in women who are using the Etonogestrel contraceptive implant.